Home > Analytics > THEMIS MEDICARE

THEMIS MEDICARE
Intrinsic Value | Fundamental Analysis

BOM : 530199     NSE : THEMISMED    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Sep 25,2023
Price(EOD): ₹ 1,761.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,620.17 Cr
Value of ₹ 1 Lac invested in THEMIS MEDICARE
on Sep 25,2018 (price: ₹ 315.00)

₹ 1 L

₹ 5.59 L

1W : 2.6% 1M : 8.1% 1Y : 78.9%
COMMUNITY POLL
for THEMIS MEDICARE
Please provide your vote to see the results
THEMIS MEDICARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
THEMIS MEDICARE 2.6% 8.1% 78.9%
SUN PHARMACEUTICAL INDUSTRIES -2.1% 0.6% 23.6%
DIVIS LABORATORIES -1.4% 2% 2%
CIPLA -5% -3.3% 8.7%
DR REDDYS LABORATORIES -5% -7.9% 30.8%
TORRENT PHARMACEUTICALS -2% -5.8% 22.5%
ABBOTT INDIA -2.8% -2.2% 24.5%
ZYDUS LIFESCIENCES -6.4% -6% 60.7%
ALKEM LABORATORIES -2.9% -4.3% 6.8%

FUNDAMENTAL ANALYSIS OF THEMIS MEDICARE

 
Fundamentals Score
[ Q(TTM): Jun2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF THEMIS MEDICARE

 
Valuation Score
[As on : Sep 25,2023 ]

Ratio Consolidated
P/E
P/B
P/S
36.66
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 44.20 Cr
[Latest Qtr - Jun2023 - Consolidated Results ]

4.78
P/B Calculated based on Book Value of Rs 339.38 Cr
[Latest Year - Mar2023 - Consolidated Results ]

4.55
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 356.54 Cr
[Latest Qtr - Jun2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 15% undervalued companies ! Discover More →

FAIR VALUE OF THEMIS MEDICARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
105%
286%
428%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF THEMIS MEDICARE


Insights 💡 THEMISMED is one of the top 33% companies with bullish price momentum currently! Discover More →

THEMIS MEDICARE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF THEMIS MEDICARE

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.32
0.46
0.63
0.47
0.27
0.39
0.54
0.4
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF THEMIS MEDICARE

Pledged Promoter Shares
23.51 %
As on : Jun2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF THEMIS MEDICARE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
20.65%
107.45%
112.99%
107.97%
2.34%
6.78%
3.36%
7.9%
QtrlyTrend
8
Latest Qtr: Jun2023
Quarterly Result Analysis →


THEMIS MEDICARE related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP -1.6% 3.3% 26.5%
S&P BSE SMALL CAP -1.9% 2.9% 27.3%
S&P BSE ALLCAP -2.2% 1.9% 13.3%
S&P BSE HEALTHCARE -3.1% -1.1% 22.6%
No NSE index found

You may also like the below Video Courses


FAQ about THEMIS MEDICARE


Is THEMIS MEDICARE good for long term investment?

As on Sep 25,2023, the Fundamentals of THEMIS MEDICARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of THEMIS MEDICARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is THEMIS MEDICARE UnderValued or OverValued?

As on Sep 25,2023, THEMIS MEDICARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of THEMIS MEDICARE ?

As on Sep 25,2023, the Intrinsic Value of THEMIS MEDICARE is Rs. 456.10 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 860.02
Fair Value [Median EV / Sales Model] : Rs. 456.10
Fair Value [Median Price / Sales Model] : Rs. 333.61
Estimated Median Fair Value of THEMIS MEDICARE : Rs. 456.10

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is THEMIS MEDICARE trading at a Premium or Discount?

As on Sep 25,2023, THEMIS MEDICARE is trading at a Premium of 286% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].